While IDO1 and TDO2 initiate the KYN-AhR pathway, influencing mast cell activation in CRSwNP [17], especially given IDO1 inhibitors’ clinical failure. The gene discussed is IDO1; the disease is chronic rhinosinusitis with nasal polyps.